Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BCAX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
BCAX
Bicara Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
BCAX
Bicara Therapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
BCAX
with
LLY
Uncorrelated: r 0.20 · 500D.
No shared co-movers.
BCAX, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
BCAX
Bicara Therapeutics Inc.
Change
7.91
▼
−0.30%
· post 8.93
· delayed
Mkt cap
$538.7M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,407.25
▼
−0.27%
· post 1,407.54
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 3 '26
delayed
BCAX
Bicara Therapeutics Inc.
vs
LLY
ELI Lilly & Co
7.91
▼
−0.30%
post 8.93
delayed
Price
1,407.25
▼
−0.27%
post 1,407.54
delayed
$538.7M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
BCAX
7.91
▼
−0.30%
vs
LLY
1,407.25
▼
−0.27%
After hours
Nov 3 '26
delayed